Study in Adult and Adolescent Subjects With PAR

Study Title
Study in Adult and Adolescent Subjects With PAR (Perennial Female, Maleergic Rhinitis)
Teva Identifier
BDP-AR-302
ClinicalTrials.gov Identifier
NCT01134705
Study Status
Completed
Trial Condition(s)
Rhinitis, Female, Maleergic, Perennial
Interventions
Drug: Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol | Drug: Placebo Nasal Aerosol

Study Description

Please refer to ClinicalTrials.gov for a description of the trial



Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
05/01/2010 - 10/01/2010
Phase
Phase 3

Study Type

Interventional